These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24715618)

  • 1. Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry.
    Paudel A; Geppi M; Mooter GVD
    J Pharm Sci; 2014 Sep; 103(9):2635-2662. PubMed ID: 24715618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pairwise polymer blends for oral drug delivery.
    Marks JA; Wegiel LA; Taylor LS; Edgar KJ
    J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance.
    Pugliese A; Tobyn M; Hawarden LE; Abraham A; Blanc F
    Mol Pharm; 2022 Nov; 19(11):3685-3699. PubMed ID: 36037249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM; Wendelboe J; Holm R; Rades T
    Eur J Pharm Biopharm; 2018 Sep; 130():290-295. PubMed ID: 30064702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.
    Ricarte RG; Van Zee NJ; Li Z; Johnson LM; Lodge TP; Hillmyer MA
    Mol Pharm; 2019 Oct; 16(10):4089-4103. PubMed ID: 31487183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide).
    Schachter DM; Xiong J; Tirol GC
    Int J Pharm; 2004 Aug; 281(1-2):89-101. PubMed ID: 15288346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.
    Purohit HS; Ormes JD; Saboo S; Su Y; Lamm MS; Mann AKP; Taylor LS
    Pharm Res; 2017 Jul; 34(7):1364-1377. PubMed ID: 28455777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
    Newman A; Nagapudi K; Wenslow R
    Ther Deliv; 2015 Feb; 6(2):247-61. PubMed ID: 25690090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
    Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
    Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.
    Lubach JW; Hau J
    Pharm Res; 2018 Feb; 35(3):65. PubMed ID: 29464409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
    Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
    Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
    Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
    Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of poorly soluble compounds by amorphous solid dispersions.
    Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
    Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability.
    Ochi M; Kimura K; Kanda A; Kawachi T; Matsuda A; Yuminoki K; Hashimoto N
    AAPS PharmSciTech; 2016 Aug; 17(4):932-9. PubMed ID: 27435198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.